Skip to main content

Table 4 Participant reported withdrawal symptoms experienced by the people who overdosed (N = 125)

From: Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders

Symptom Percent of participants experiencing the symptom [n (%)]
Overall (N = 125) 1 spray administered (n = 28)  ≥ 2 sprays administered (n = 97)
Confusion 76 (61%) 17 (61%) 59 (61%)
Agitated/Angry 63 (50%) 15 (54%) 48 (49%)
Body weakness 63 (50%) 13 (46%) 50 (52%)
Nausea 61 (49%) 13 (46%) 48 (49%)
Shivering 58 (46%) 14 (50%) 44 (45%)
Sweating 52 (42%) 12 (43%) 40 (41%)
Headaches 50 (40%) 8 (29%) 42 (43%)
Dizziness 46 (37%) 8 (29%) 38 (39%)
Vomiting 42 (34%) 10 (36%) 32 (33%)
Body pain 26 (21%) 6 (21%) 20 (21%)
Nasal congestion 15 (12%) 4 (14%) 11 (11%)
Nasal dryness 15 (12%) 0 (0%) 15 (15%)
Yawning 13 (10%) 2 (7%) 11 (11%)
Other 11 (9%) 1 (4%) 10 (10%)
None 2 (2%) 0 (0%) 2 (2%)